Search Results 1111-1120 of 17190 for hypnosis

  1. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    Approximately 358 patients will be randomized in a 1:1 ratio to DCC-2618 150 mg once daily (QD) (continuous dosing for 6 week cycles) or sunitinib 50 mg QD (6 ...

  2. Publications - Jacob M. Core, D.O. - Mayo Clinic

    Zaazoue KA, ElBoraey MA, Core J, Devcic Z, Frey GT, Lewis AR, McKinney JM, Paz-Fumagalli R, Toskich BB, Ritchie CA. Percutaneous Mechanical Thrombectomy as ...

  3. Surgery - Doctors - Mayo Clinic

    Mayo Clinic Surgery offers deep expertise and a wide range of surgical care to tens of thousands of people each year.

  4. Surgery - Doctors - Mayo Clinic

    Mayo Clinic Surgery offers deep expertise and a wide range of surgical care to tens of thousands of people each year.

  5. Publications - Andrew I. Vaughn, M.D., M.P.H. - Mayo Clinic

    Swift MD, Molella RG, Vaughn AIS, Breeher LE, Newcomb RD, Abdellatif S, Murad MH. Determinants of Latent Tuberculosis Treatment Acceptance and Completion in ...

  6. Doxepin (oral route) - Side effects & dosage - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  7. Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely ...

  9. Medical Research & Education - Mayo Clinic News Network

    Dr. Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Cardiovascular risks ...

  10. Medical Research & Education - Mayo Clinic News Network

    New drug may reduce need for aortic valve surgeries by slowing disease progression. ROCHESTER, Minn. — Aortic valve stenosis (AVS) is a significant health ...